approval
saveHYRIMOZ (ADALIMUMAB-ADAZ) — FDA approval
community read0 votes
Sponsor: SANDOZ INC. Form: INJECTABLE. Route: INJECTION
view source ↗Data sources
last refreshed 5mo ago
Found something off?
drug timeline · 8
- approvalHYRIMOZ (ADALIMUMAB-ADAZ) — FDA approvalOct 16, 2025 · 353d ago
- approvalHYRIMOZ (ADALIMUMAB-ADAZ) — FDA approvalJul 29, 2025 · 432d ago
- approvalHYRIMOZ (ADALIMUMAB-ADAZ) — FDA approvalMay 20, 2025 · 502d ago
- approvalHYRIMOZ (ADALIMUMAB-ADAZ) — FDA approvalApr 5, 2024 · 912d ago
- approvalHYRIMOZ (ADALIMUMAB-ADAZ) — FDA approvalSep 8, 2023 · 1122d ago
- approvalHYRIMOZ (ADALIMUMAB-ADAZ) — FDA approvalApr 14, 2023 · 1269d ago
- approvalHYRIMOZ (ADALIMUMAB-ADAZ) — FDA approvalMar 20, 2023 · 1294d ago
- approvalHYRIMOZ (ADALIMUMAB-ADAZ) — FDA approvalJul 18, 2022 · 1539d ago
same company · ±60 days · 6
- approvalamoxicillin: AMOXICILLIN AND CLAVULANATE POTASSIUM (AMOXICILLIN) — FDA approvalJun 24, 2024
- approvalondansetron ODT: ONDANSETRON — FDA approvalMay 31, 2024
- approvalondansetron ODT: ONDANSETRON — FDA approvalMay 31, 2024
- approvalONDANSETRON — FDA approvalJun 26, 2024
- approvalONDANSETRON — FDA approvalJun 26, 2024
- approvalGABAPENTIN: GABAPENTIN — FDA approvalJul 16, 2024
comments(0)
5-min edit window · permanent after that